换一批A pilot study of increasing dose intensity of epirubicin and ifosfamide in patients with small cell lung cancer by using recombinant granulocyte colony-stimulating factor.
第一作者：
P A,Philip
第一单位：
Imperial Cancer Research Fund, Clinical Oncology Unit, Oxford University, UK.
作者：
医学主题词
老年人(Aged);抗生素类, 抗肿瘤(Antibiotics, Antineoplastic);抗肿瘤药, 烷基化(Antineoplastic Agents, Alkylating);抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);癌, 小细胞(Carcinoma, Small Cell);队列研究(Cohort Studies);用药计划表(Drug Administration Schedule);表柔比星(Epirubicin);女(雌)性(Female);粒细胞集落刺激因子(Granulocyte Colony-Stimulating Factor);人类(Humans);异环磷酰胺(Ifosfamide);肺肿瘤(Lung Neoplasms);男(雄)性(Male);中年人(Middle Aged);中性粒细胞减少(Neutropenia);试点项目(Pilot Projects);前瞻性研究(Prospective Studies);重组蛋白质类(Recombinant Proteins);治疗结果(Treatment Outcome)
DOI
10.1053/clon.1999.9019
PMID
10378632
发布时间
2019-09-15
- 浏览24
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
